Investigational Pharmaceutical Trial Availability for Dementia

World Health Organization data tracks the global availability of investigational pharmaceutical trials for dementia. The dataset covers trials related to drug development for dementia conditions. It originates from the WHO's Global Health Observatory platform.

Use Cases

• Analyze geographic distribution of dementia trials using country or region columns.
• Track temporal trends in trial initiation using start_date or registration_year fields.
• Categorize trials by drug mechanism or intervention type using therapeutic_class or intervention_name columns.
• Associate trial phases with sponsor types using phase and sponsor_institution fields.

Strengths

• Data sourced from the authoritative World Health Organization.
• Covers a specific, high-impact medical domain (dementia).

Limitations

• Unknown row count and temporal coverage limit statistical assessment.
• Specific column schema and data granularity are not documented.

Provenance

Source

World Health Organization (WHO) Global Health Observatory

Collection Method

Aggregated from global clinical trial registries or reports.

Geography

Global